OncohematologyOncohematologyОнкогематология1818-83462413-4023Publishing House ABV Press86810.17650/1818-8346-2023-18-4-64-69HEMATOLOGIC MALIGNANCIES: TREATMENTЛЕЧЕНИЕ ГЕМОБЛАСТОЗОВCombination of lymphoproliferative diseases and pregnancyСочетание лимфопролиферативных заболеваний и беременностиhttps://orcid.org/0000-0002-8194-2811ChernyshovaA. L.ЧернышоваA. Л.
Russian Federation

Alena L. Chernyshova 

5 Kooperativnyy Pereulok, Tomsk 634009

Алена Леонидовна Чернышова 

634009 Томск, пер. Кооперативный, 5

alacher@list.ruhttps://orcid.org/0000-0003-0829-0340ChernyakovA. A.ЧерняковA. А.
Russian Federation

5 Kooperativnyy Pereulok, Tomsk 634009

634009 Томск, пер. Кооперативный, 5

https://orcid.org/0000-0001-5294-778XPopovaN. O.ПоповаН. О.
Russian Federation

5 Kooperativnyy Pereulok, Tomsk 634009

634009 Томск, пер. Кооперативный, 5

https://orcid.org/0000-0002-2048-3404KravchukT. L.КравчукТ. Л.
Russian Federation

5 Kooperativnyy Pereulok, Tomsk 634009

634009 Томск, пер. Кооперативный, 5

TrushchukYu. M.ТрущукЮ. М.
Russian Federation

5 Kooperativnyy Pereulok, Tomsk 634009

634009 Томск, пер. Кооперативный, 5

https://orcid.org/0000-0001-6562-7574Dil’O. S.ДильО. С.
Russian Federation

5 Kooperativnyy Pereulok, Tomsk 634009

634009 Томск, пер. Кооперативный, 5

https://orcid.org/0000-0003-0687-0894Krasil’nikovS. E.КрасильниковС. Э.
Russian Federation

15 Rechkunovskaya St., Novosibirsk 630055

630055 Новосибирск, ул. Речкуновская, 15

https://orcid.org/0000-0003-3522-4920AntipovV. A.АнтиповВ. А.
Russian Federation

15 Rechkunovskaya St., Novosibirsk 630055

630055 Новосибирск, ул. Речкуновская, 15

ShumeykinaA. O.ШумейкинаА. О.
Russian Federation

15 Rechkunovskaya St., Novosibirsk 630055

630055 Новосибирск, ул. Речкуновская, 15

Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of SciencesНаучно-исследовательский институт онкологии – филиал ФГБНУ «Томский национальный исследовательский медицинский центр Российской академии наук»E.N. Meshalkin National Medical Research Center, Ministry of Health of RussiaФГБУ «Национальный медицинский центр им. акад. Е.Н. Мешалкина» Минздрава Россииru091220232023184646907122023Received:07122023Published:09122023https://oncohematology.abvpress.ru/ongm/article/view/868

The article presents an analysis of the current state of the problem of the combination of lymphoproliferative diseases associated with pregnancy. Analysis of literature sources has shown that despite the seemingly obvious unfavorable relationship between pregnancy and lymphoproliferative diseases, most studies demonstrate a favorable prognosis regarding the prognosis and outcome of this oncological pathology in combination with pregnancy. The Research Institute of Oncology of the Tomsk SRI has sufficient experience in the treatment of this pathology, including on the background of pregnancy. We have presented two clinical cases in which successful treatment of lymphoproliferative processes in pregnant women has been demonstrated.

В статье представлен анализ современного состояния проблемы сочетания лимфопролиферативных заболеваний, ассоциированных с беременностью. Результаты большинства исследований демонстрируют благоприятный прогноз в отношении исхода лимфопролиферативных заболеваний у беременных. В НИИ онкологии Томского НИМЦ имеется достаточный опыт лечения данной патологии, в том числе на фоне беременности. В статье представлены 2 клинических случая, в которых продемонстрировано успешное лечение лимфопролиферативных процессов у беременных женщин.

pregnancyHodgkin’s lymphomatreatmentprognosisбеременностьлимфома ходжкиналечениепрогнозState of oncological care in Russia in 2021. Eds.: А.D. Kaprin, V.V. Starinskiy, A.O. Shachzadova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2022. 239 p. (In Russ.).Состояние онкологической помощи населению России в 2021 году. Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022. 239 с.Zhang J., Shynlova O., Sabra S. et al. Immunophenotyping and activation status of maternal peripheral blood leukocytes during pregnancy and labour, both term and preterm. J Cell Mol Med 2017;21(10):2386–402. DOI: 10.1111/jcmm.13160Abu-Raya B., Michalski C., Sadarangani M., Lavoie P.M. Maternal immunological adaptation during normal pregnancy. Front Immunol 2020;11:575197. DOI: 10.3389/fimmu.2020.575197Mehta A.K., Kadel S., Townsend M.G. et al. Macrophage biology and mechanisms of immune suppression in breast cancer. Front Immunol 2021;12:643771. DOI: 10.3389/fimmu.2021.643771Jungles K.M., Holcomb E.A., Pearson A..N et al. Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer. Front Oncol 2022;12:1022542. DOI: 10.3389/fonc.2022.1022542Ruocco M.G., Chaouat G., Florez L. et al. Regulatory T-cells in pregnancy: historical perspective, state of the art, and burning questions. Front Immunol 2014;5:389. DOI: 10.3389/fimmu.2014.00389Kushekhar K., van den Berg A., Nolte I. et al. Genetic associations in classical hodgkin lymphoma: a systematic review and insights into susceptibility mechanisms. Cancer Epidemiol Biomark Prev 2014;23(12):2737–47. DOI: 10.1158/1055-9965.EPI-14-0683Gaudio F., Perrone T., Mestice A. et al. Peripheral blood CD4/ CD19 cell ratio is an independent prognostic factor in classical Hodgkin lymphoma. Leuk Lymphoma 2014;55(7):1596–601. DOI: 10.3109/10428194.2013.854889Gaudio F., Nardelli C., Masciandaro P. et al. Pregnancy rate and outcome of pregnancies in long-term survivors of Hodgkin’s lymphoma. Ann Hematol 2019;98(8):1947–52. DOI: 10.1007/s00277-019-03684-0Maggen C., Dierickx D., Lugtenburg P. et al. International Network on Cancer, Infertility and Pregnancy. Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study. Lancet Haematol 2019;6(11):e551–61. DOI: 10.1016/S2352-3026(19)30195-4Chernyshova A.L., Kolomiets L.A., Chernyakov A.A. et al. Features of the course of melanoma during pregnancy. Voprosy onkologii = Problems in Oncology 2023;69(2):322–7. (In Russ.). DOI: 10.37469/0507-3758-2023-69-2-322-327Чернышова А.Л., Коломиец Л.А., Черняков А.А. и др. Особенности течения меланомы на фоне беременности. Вопросы онкологии 2023;69(2):322–7. DOI: 10.37469/0507-3758-2023-69-2-322-327Dell’Aquila K., Hodges H., Moshiri M. et al. Imaging evaluation of lymphoma in pregnancy with review of clinical assessment and treatment options. Abdom Radiol (NY) 2023;48(5):1663–78. DOI: 10.1007/s00261-022-03779-9Moshe Y., Bentur O.S., Lishner M., Avivi I. The management of Hodgkin lymphomas in pregnancies. Eur J Haematol 2017;99(5):385–91. DOI: 10.1111/ejh.12956Shah M.R., Brandt J.S., David K.A., Evens A.M. Lymphoma occurring during pregnancy: current diagnostic and therapeutic approaches. Curr Oncol Rep 2020;22(11):113. DOI: 10.1007/s11912-020-00972-1Aviles A., Nambo M.J., Neri N. Lymphoma and pregnancy. Jpn J Clin Oncol 2017;47(5):467–8. DOI: 10.1093/jjco/hyx004Di Ciaccio P.R., Mills G., Shipton M.J. et al. The clinical features, management and outcomes of lymphoma in pregnancy: a multicentre study by the Australasian Lymphoma Alliance. Br J Haematol 2023;201(5):887–96. DOI: 10.1111/bjh.18727El-Messidi A., Patenaude V., Abenhaim H.A. Incidence and outcomes of women with non-Hodgkin’s lymphoma in pregnancy: a population-based study on 7.9 million births. J Obstet Gynaecol Res 2015;41(4):582–9. DOI: 10.1111/jog.12597Maggen C., Dierickx D., Cardonick E. et al. International Network on Cancer Infertility Pregnancy (INCIP). Maternal and neonatal outcomes in 80 patients diagnosed with non-Hodgkin lymphoma during pregnancy: results from the International Network of Cancer, Infertility and Pregnancy. Br J Haematol 2021;193(1):52–62. DOI: 10.1111/bjh.17103Flint T.R., Jones J.O., Ferrer M. et al. A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy. Sem Oncol 2018;45(3):170–5. DOI: 10.1053/j.seminoncol.2018.03.005Luttwak E., Gurevich-Shapiro A., Azem F. et al. Novel agents for the treatment of lymphomas during pregnancy: a comprehensive literature review. Blood Rev 2021;49:100831. DOI: 10.1016/j.blre.2021.100831On S., Chang A. Treatment of lymphoma with rituximab and chemotherapy during pregnancy. Leuk Lymphoma 2022;63(12):2897–904. DOI: 10.1080/10428194.2022.2100368